PD-L1 is an immune checkpoint protein that is highly expressed in a variety of cancers including breast cancer, and which can promote the immune escape of cancer cells by binding to PD-1 on T cells [5] In this study, we measured the expression of PD-L1 in tumor cells after drug treatment in each group by immunohistochemistry. Here, CD274 is linked to breast carcinoma.